Potential of the Trifunctional Bispecific Antibody Surek Depends on Dendritic Cells: Rationale for a New Approach of Tumor Immunotherapy by Nina Eissler, Josef Mysliwietz, Nina Deppisch, Peter Ruf, Horst Lindhofer, Ralph Mocikat

Get full text

Removal of EpCAM-positive tumor cells from blood collected during major oncological surgery using the Catuvab device- a pilot study by Andreas Winter, Kai Zacharowski, Patrick Meybohm, Andreas Schnitzbauer, Peter Ruf, Claudia Kellermann, Horst Lindhofer

Get full text

GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma by Annette Künkele, Angelika Eggert, Johannes H Schulte, Anika Klaus, Horst Lindhofer, Felix Zirngibl, Sara M Ivasko, Laura Grunewald, Silke Schwiebert, Peter Ruf, Kathy Astrahantseff, Lena Andersch, Holger N Lode, Kathleen Anders, Patrick Hundsdoerfer

Get full text

Combination of GD2-directed bispecific trifunctional antibody therapy with Pd-1 immune checkpoint blockade induces anti-neuroblastoma immunity in a syngeneic mouse model by Sara Marie Ivasko, Sara Marie Ivasko, Kathleen Anders, Kathleen Anders, Laura Grunewald, Michael Launspach, Michael Launspach, Anika Klaus, Silke Schwiebert, Peter Ruf, Horst Lindhofer, Holger N. Lode, Lena Andersch, Johannes H. Schulte, Johannes H. Schulte, Johannes H. Schulte, Angelika Eggert, Angelika Eggert, Angelika Eggert, Patrick Hundsdoerfer, Patrick Hundsdoerfer, Annette Künkele, Annette Künkele, Annette Künkele, Annette Künkele, Felix Zirngibl, Felix Zirngibl

Get full text